NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/06/2025
Back to search
Official data from USPTO
LA JOLLA PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LA JOLLA PHARMACEUTICAL
ST13
US500000087312982Class
5
Filing
87312982
Registration
5515707
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/06/2025
Trademark type
Word
Nice classes
5
Filing date
01/25/2017
Registration date
07/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/06/2025
Last transaction
03/06/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
02/05/2018
First use in commerce
02/05/2018
Drawing code
4
Owner type
03
Owner location
Waltham, MA
Examiner
MULLEN, MARK
Current location
Historical data usage
Holders and representatives
Holders
LA JOLLA PHARMACEUTICAL COMPANY
LA JOLLA PHARMACEUTICAL COMPANY
Representatives
Nicole Kinsley, Esq. FOLEY HOAG LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
house mark for pharmaceutical products for human usepharmaceuticals for the treatment of hypotension and antihypotensive agents
Publications
History of USPTO decisions and trademark events.
38 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/22/2024
ES8R
TEAS SECTION 8 RECEIVED
07/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/10/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/10/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/05/2018
ALIE
ASSIGNED TO LIE
05/31/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/17/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/16/2018
IUAA
USE AMENDMENT ACCEPTED
05/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/15/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/11/2018
IUAF
USE AMENDMENT FILED
05/11/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/10/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/10/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/19/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/19/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/15/2017
GNFR
FINAL REFUSAL E-MAILED
11/15/2017
CNFR
FINAL REFUSAL WRITTEN
11/15/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/26/2017
GNRT
NON-FINAL ACTION E-MAILED
04/26/2017
CNRT
NON-FINAL ACTION WRITTEN
04/26/2017
DOCK
ASSIGNED TO EXAMINER
04/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2017
NWAP
NEW APPLICATION ENTERED
01/28/2017
Continuous trademark protection
Get notified about every new filing that threatens LA JOLLA PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.